S, M., F, C., M, B., C, B., MG, M., A, T., . . . Maltinti, G. (2001). Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology, 13(5), 547-551.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
S, Marchi, et al. "Ranitidine Bismuth Citrate-based Triple Therapy for Seven Days, with or Without Further Anti-secretory Therapy, Is Highly Effective in Patients with Duodenal Ulcer and Helicobacter Pylori Infection."
European Journal of Gastroenterology & Hepatology 13, no. 5 (2001): 547-551.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
S, Marchi, et al. "Ranitidine Bismuth Citrate-based Triple Therapy for Seven Days, with or Without Further Anti-secretory Therapy, Is Highly Effective in Patients with Duodenal Ulcer and Helicobacter Pylori Infection."
European Journal of Gastroenterology & Hepatology, vol. 13, no. 5, 2001, pp. 547-551.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.